Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2032331
SINGAPORE, U0
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,523,594
-$1,509 QoQ
Shares Held
3,412
+1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2025CallValue
$775,712
CallShares
1,600
PutValue
$969,640
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $30,661,650 across 36 Biotechnology names. VRTX ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
38,988 | $2,927,608 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
16,401 | $2,772,097 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
48,719 | $2,752,136 | |
| 4 | ASND |
Ascendis Pharma A/S
|
11,828 | $2,705,418 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
39,701 | $2,704,829 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,502 | $1,933,145 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,412 | $1,523,594 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
3,855 | $1,242,042 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,523,594 | 3,412 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,525,103 | 3,364 | Shares | Defined | 2026-02-11 | |
| 2025-03-31 | $775,712 | 1,600 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $969,640 | 2,000 | Put | Defined | 2025-05-13 | |
| 2025-03-31 | $221,562 | 457 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,570,530 | 3,900 | Put | Defined | 2025-02-18 | |
| 2024-12-31 | $1,852,420 | 4,600 | Call | Defined | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||